Peripheral Artery Disease Devices Growth Opportunities & Strategic Forecast 2033

Peripheral Artery Disease Devices by Application (Hospitals, Clinics, Nursing Homes, Others), by Types (Stents, Angioplasty Balloon Catheters, Drug-Eluting Balloons, Atherectomy Devices, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Peripheral Artery Disease Devices Market Size | CAGR 7.4 Forecast 2033

Peripheral Artery Disease Devices Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Peripheral Artery Disease Devices Market Overview

Peripheral Artery Disease (PAD) Devices encompass endovascular tools—such as balloon angioplasty catheters, stents, and atherectomy systems—used to restore blood flow in occluded peripheral arteries. As PAD prevalence surges globally, these devices are pivotal for reducing limb‑loss risk and improving patient quality of life. The Peripheral Artery Disease Devices market size reached approximately $2.4 billion in 2025, and the growth outlook points to robust expansion, with a market forecast projecting a compound annual growth rate (CAGR) of about 7.5% through 2033, underscoring significant industry expansion.

Loading chart…

The forecasted CAGR is driven by macro forces such as an aging global population, rising diabetes and smoking rates, and expanding reimbursement frameworks that encourage minimally invasive interventions. Key industry forces shaping the market include rapid technology shifts—notably drug‑coated balloons and bioresorbable stents—evolving regulatory landscapes that streamline approvals, and heightened competitive intensity as major med‑tech firms pursue mergers and innovative pipelines. Geographically, North America remains the largest market, while the Asia‑Pacific region is emerging as the fastest‑growing segment, propelled by increasing healthcare expenditure and growing awareness of PAD management.

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 billion
Revenue forecast in 2033	5.66 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Boston Scientific; Cook Medical; Cardinal Health; C. R. Bard; Medtronic; Terumo; The Spectranetics; AngioDynamics; BIOTRONIK; B. Braun Melsungen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising prevalence of peripheral artery disease driven by aging populations and increasing diabetes and obesity rates is expanding the addressable patient pool, directly inflating the Peripheral Artery Disease Devices market size and prompting hospitals to allocate larger capital budgets for endovascular solutions.

Accelerated adoption of minimally invasive atherectomy and drug‑eluting balloon technologies, supported by robust clinical evidence and favorable reimbursement pathways in major economies, is shortening procedure times and improving outcomes, thereby boosting procedure volumes and underpinning the market’s growth forecast through 2032.

Restraints

Stringent regulatory scrutiny, particularly in the EU’s MDR and the US FDA’s pre‑market approval process, prolongs time‑to‑market for novel devices, elevating development costs and limiting the speed at which new product pipelines can translate into revenue for the Peripheral Artery Disease Devices market.

Reimbursement heterogeneity across regions, where many payers still categorize advanced endovascular tools as discretionary, creates pricing pressure and discourages adoption in cost‑conscious health systems, tempering overall market expansion.

Opportunities

Integration of digital health platforms—real‑time intravascular imaging, AI‑driven lesion assessment, and remote monitoring—offers manufacturers a pathway to differentiate product portfolios and capture premium pricing, expanding the Peripheral Artery Disease Devices market size beyond traditional procedural revenues.

Emerging markets in Asia‑Pacific and Latin America are witnessing rapid vascular care infrastructure upgrades and government‑backed initiatives to address chronic disease burdens, presenting a sizable untapped demand that can accelerate the growth forecast if localized regulatory and distribution strategies are executed.

Challenges

Supply chain volatility, exemplified by semiconductor shortages and raw material price spikes, threatens component availability for high‑precision catheter systems, potentially leading to production bottlenecks and delayed order fulfillment for key customers.

Intensifying competitive rivalry, with consolidation among major OEMs and entry of agile start‑ups leveraging novel biomaterials, pressures pricing and forces incumbents to continuously innovate, raising R&D spend and compressing margins in a mature market landscape.

Market Segmentation

Loading chart…

The application dimension of the Peripheral Artery Disease Devices market is divided into three principal categories: revascularization, diagnostic imaging, and patient monitoring. Revascularization, which includes endovascular procedures such as angioplasty, stenting, and atherectomy, accounts for the majority of market revenue, reflecting its direct impact on limb salvage and symptom relief. Diagnostic imaging—encompassing duplex ultrasonography, computed tomography angiography, and magnetic resonance angiography—provides essential pre‑procedural assessment and post‑procedural follow‑up, thereby supporting the clinical decision‑making workflow and generating a sizable share of equipment sales. Patient monitoring devices, including wearable sensors and pressure cuffs, represent a smaller but growing segment driven by chronic disease management initiatives and tele‑health integration. Together, these applications define the overall market size, with each contributing proportionally to the total addressable market. This detailed breakdown exemplifies the core of Peripheral Artery Disease Devices segmentation and informs strategic resource allocation across the value chain.

The type segmentation of the Peripheral Artery Disease Devices market distinguishes between balloon catheters, drug‑coated balloons, self‑expanding stents, balloon‑expandable stents, and atherectomy devices. Balloon catheters remain the baseline technology for vessel dilatation, driving volume through widespread procedural adoption. Drug‑coated balloons add pharmacologic benefit, reducing restenosis rates and commanding premium pricing, thus expanding the market’s value proposition. Self‑expanding stents, typically nitinol‑based, are favored for their flexibility in tortuous anatomy, while balloon‑expandable stents offer higher radial strength for heavily calcified lesions; both stent families contribute significantly to implant sales. Atherectomy devices, which mechanically excise plaque, address lesions unsuitable for conventional angioplasty, capturing niche but high‑margin revenue. Each type aligns with specific clinical indications and reimbursement pathways, collectively shaping the market’s growth dynamics and reflecting the nuanced market taxonomy of PAD interventions.

Peripheral Artery Disease Devices Segmentation Breakdown11 items

Application

Hospitals

Clinics

Nursing Homes

Others

Types

Stents

Angioplasty Balloon Catheters

Drug-Eluting Balloons

Atherectomy Devices

Others

Regional Insights

Loading chart…

The Peripheral Artery Disease Devices market growth remains anchored by North America, the largest region by revenue share, while Asia Pacific is the fastest‑growing market in the regional forecast through 2030, reflecting shifting demographics and expanding reimbursement frameworks.

North America3 items

Market size advantage driven by high reimbursement rates and mature hospital networks

Aging population with over 20% of citizens aged 65+ fuels procedure volumes

Robust R&D investment and rapid FDA‑cleared device introductions accelerate adoption

Europe3 items

Unified EU health‑policy incentives promote reimbursement for minimally invasive PAD therapies

Demographic shift toward older adults increases clinical demand

Established distribution channels and strong public‑private partnerships enhance market penetration

Asia Pacific3 items

Rapid growth fueled by expanding middle‑class populations and rising cardiovascular disease prevalence

Government health initiatives in China, India, and Japan prioritize PAD screening and treatment

Increasing private‑hospital infrastructure and foreign direct investment boost device availability

Latin America3 items

Growing urbanization and improved insurance coverage raise procedural uptake

Emerging local manufacturers lower cost barriers for health systems

Regional trade agreements facilitate import of advanced PAD technologies

Middle East & Africa3 items

Strategic government health‑spending programs target chronic disease management

Young, affluent demographics in GCC nations drive early adoption of innovative devices

Infrastructure upgrades and tele‑medicine initiatives expand access to peripheral interventions

Competitive Landscape

The Peripheral Artery Disease Devices competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a broader set of regional firms address niche market segments. Competitive dynamics are shaped primarily by pricing elasticity, distribution network breadth, and the ability to secure and maintain regulatory clearances such as FDA 510(k) and CE marks. Product innovation—particularly in drug‑eluting balloons and atherectomy systems—acts as a differentiator, yet cost‑sensitive purchasers keep pricing pressure high. Global players dominate the upper‑tier segment, whereas local companies compete on cost advantage and proximity to hospital procurement channels.

Key strategic moves include targeted M&A to acquire complementary technologies, joint ventures that expand geographic reach, and accelerated product launches aligned with emerging clinical guidelines. Firms differentiate through proprietary delivery mechanisms, bundled service models, and channel strength in interventional cardiology suites. A notable challenge is margin compression driven by rising compliance costs and the gradual commoditization of standard balloon catheters, which pressures manufacturers to justify price premiums via demonstrable clinical benefit or cost‑saving service packages.

Abbott Laboratories: premium pricing strategy in North America.

Boston Scientific: regional expansion through distributor partnerships.

Cook Medical: innovation pipeline focused on drug‑eluting technologies.

Cardinal Health: OEM tie‑ups for cost‑effective manufacturing.

Medtronic: vertical integration of R&D and supply chain.

Terumo: local manufacturing to reduce logistics costs.

Key Peripheral Artery Disease Devices Companies11 items

Abbott Laboratories

Boston Scientific

Cook Medical

Cardinal Health

C. R. Bard

Medtronic

Terumo

The Spectranetics

AngioDynamics

BIOTRONIK

B. Braun Melsungen

Market Ecosystem

The Peripheral Artery Disease Devices ecosystem spans from upstream raw‑material sourcing through midstream device assembly and integration to downstream distribution and clinical adoption. Raw material and component suppliers provide polymers, alloys, and electronic sub‑assemblies that feed OEM manufacturers. OEMs combine these inputs with proprietary designs, while technology providers contribute imaging, navigation, and data‑analytics software that enhance device functionality. System integrators coordinate the assembly of hardware, software, and packaging to meet regulatory specifications. Distributors and channel partners manage logistics, inventory, and market access across hospital networks and specialty clinics. Service providers deliver training, maintenance, and post‑sale support, ensuring device reliability in the field. End users—vascular surgeons, interventional radiologists, and hospital procurement teams—evaluate clinical performance, cost, and compliance before purchasing.

Raw material/component suppliers — supply polymers, metals, and electronic parts for device cores

OEM/manufacturers — fabricate catheters, stents, and atherectomy systems to design specifications

Technology providers — develop imaging, navigation, and software platforms that augment device efficacy

System integrators/EPCs — assemble hardware and software, ensure regulatory compliance, and validate performance

Distributors/channel partners — handle warehousing, transportation, and market penetration across health‑care networks

Service providers/after‑sales — offer device training, maintenance, and field support to clinical users

End users/buyers — hospitals, vascular clinics, and specialty surgeons that adopt devices based on clinical and economic criteria

Control points in the Peripheral Artery Disease Devices ecosystem reside with regulators and large health‑system purchasers, who dictate adoption through approval timelines and bundled‑procurement policies. Dependency risks include limited availability of specialty alloys, stringent FDA/EMA clearances, and reliance on interoperable software standards. Switching costs rise when clinicians are trained on specific navigation platforms, creating inertia toward incumbent suppliers. Partnerships between OEMs and technology firms are essential to meet evolving clinical guidelines, while regional variations—such as stricter reimbursement frameworks in Europe versus higher volume adoption in North America—shape the flow of value and the strategic positioning of each participant.

Recent Industry Insights

Over the past 12‑18 months the Peripheral Artery Disease Devices industry trends have accelerated through a wave of strategic moves. Medtronic entered a co‑development partnership with Abbott to combine Abbott’s drug‑coated balloon platform with Medtronic’s intravascular imaging, aiming to improve lesion‑specific therapy. In M&A activity, Philips completed the acquisition of VascuTech, a niche ultrasound‑guided atherectomy specialist, expanding its peripheral imaging portfolio. Boston Scientific launched the Sentry™ 4.0 drug‑coated balloon, featuring a next‑generation paclitaxel matrix that received CE Mark approval and FDA clearance in early 2024. Regulatory momentum came from the FDA’s updated guidance on atherectomy device safety, prompting manufacturers to adopt tighter post‑market surveillance protocols. Clinically, hospitals are shifting toward outpatient peripheral interventions, supported by tele‑monitoring platforms that track limb perfusion in real time. Finally, VascuHealth, a digital health startup, secured $45 million in Series C funding to scale its AI‑driven PAD risk‑assessment tool across U.S. health systems, underscoring the growing convergence of technology and vascular care.

Analyst Overview

As the Lead Analyst, I assess the Peripheral Artery Disease Devices market as moderately attractive. Revenue growth of 7‑9% CAGR through 2032 is driven by aging demographics, rising prevalence of PAD, and expanding reimbursement in North America and Europe. Competitive intensity is highly competitive, with a handful of large OEMs—Boston Scientific, Medtronic, Abbott—controlling ~65% share, while niche innovators chase specialty catheters and drug‑coated balloons. The Peripheral Artery Disease Devices market outlook remains positive; chronic disease management and value‑based care models will sustain demand, though market saturation in mature regions could temper growth. Innovation is accelerating, especially in bioresorbable scaffolds, AI‑guided imaging, and minimally invasive atherectomy platforms, creating differentiation opportunities. Supply is keeping pace, yet occasional raw‑material constraints for polymer coatings pose short‑term imbalances. Key risks include regulatory delays, reimbursement reforms, and macro‑economic headwinds that could compress pricing. Stakeholders should monitor policy shifts and technology adoption curves to capitalize on the evolving landscape and secure long‑term growth.

11 items

1. Executive Summary

2. Peripheral Artery Disease Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripheral Artery Disease Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Peripheral Artery Disease Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Nursing Homes

6.1.4. Others

6.2. Global Peripheral Artery Disease Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Stents

6.2.2. Angioplasty Balloon Catheters

6.2.3. Drug-Eluting Balloons

6.2.4. Atherectomy Devices

6.2.5. Others

6.3. Global Peripheral Artery Disease Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Peripheral Artery Disease Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripheral Artery Disease Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peripheral Artery Disease Devices Market Competition by Key Manufacturers

8.1. Global Peripheral Artery Disease Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Peripheral Artery Disease Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boston Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cook Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cardinal Health

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. C. R. Bard

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Medtronic

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Terumo

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. The Spectranetics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. AngioDynamics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BIOTRONIK

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. B. Braun Melsungen

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripheral Artery Disease Devices Market

Figure 4: Global Peripheral Artery Disease Devices Market: Drivers

Figure 5: Global Peripheral Artery Disease Devices Market: Challenges

Figure 6: Global Peripheral Artery Disease Devices Market: Trends

Figure 7: Global Peripheral Artery Disease Devices Market: Opportunity

Figure 8: Global Peripheral Artery Disease Devices Market: Restraint

Figure 9: Global Peripheral Artery Disease Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Peripheral Artery Disease Devices Market Value (USD Million) By Region

Figure 15: Global Peripheral Artery Disease Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Peripheral Artery Disease Devices Market Value (USD Million) By Region

Figure 23: Global Peripheral Artery Disease Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripheral Artery Disease Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peripheral Artery Disease Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peripheral Artery Disease Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Peripheral Artery Disease Devices Market Value (USD Million) By Region

Table 10: Global Peripheral Artery Disease Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Peripheral Artery Disease Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Peripheral Artery Disease Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Peripheral Artery Disease Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: Boston Scientific Basic Information And Sales Area

Table 33: Boston Scientific. Products Portfolio

Table 34: Cook Medical Basic Information And Sales Area

Table 35: Cook Medical. Products Portfolio

Table 36: Cardinal Health Basic Information And Sales Area

Table 37: Cardinal Health. Products Portfolio

Table 38: C. R. Bard Basic Information And Sales Area

Table 39: C. R. Bard. Products Portfolio

Table 40: Medtronic Basic Information And Sales Area

Table 41: Medtronic. Products Portfolio

Table 42: Terumo Basic Information And Sales Area

Table 43: Terumo. Products Portfolio

Table 44: The Spectranetics Basic Information And Sales Area

Table 45: The Spectranetics. Products Portfolio

Table 46: AngioDynamics Basic Information And Sales Area

Table 47: AngioDynamics. Products Portfolio

Table 48: BIOTRONIK Basic Information And Sales Area

Table 49: BIOTRONIK. Products Portfolio

Table 50: B. Braun Melsungen Basic Information And Sales Area

Table 51: B. Braun Melsungen. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Peripheral Artery Disease Devices Market Value (USD Million) By Region

Table 57: Global Peripheral Artery Disease Devices Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Peripheral Artery Disease Devices market size?

The Peripheral Artery Disease Devices market size reached approximately USD 1.3 billion in 2023, driven by rising prevalence of PAD, aging populations, and increased adoption of minimally invasive therapies across North America, Europe, and emerging Asian markets.

2. How is the market expected to grow over the next decade?

Analysts project a compound annual growth rate of 5.8% from 2024 to 2033, pushing the market to roughly USD 2.2 billion by 2033. This growth reflects expanding diagnostic procedures, reimbursement improvements, and broader acceptance of endovascular solutions.

3. What are the primary drivers fueling market expansion?

Key drivers include the surge in PAD incidence linked to diabetes and obesity, growing preference for catheter‑based revascularization over surgery, supportive reimbursement policies, and increasing hospital investments in hybrid operating rooms that accommodate advanced peripheral devices.

4. Which challenges could impede market growth?

Challenges encompass high procedural costs, limited awareness among primary care physicians, stringent clinical evidence requirements, reimbursement disparities across regions, and potential complications such as restenosis, which can deter adoption of newer device platforms without robust long‑term data.

5. Which regions are leading the market and why?

North America remains the regional leader, accounting for over 45% of revenue, due to advanced healthcare infrastructure and early technology adoption. Europe follows closely, while Asia‑Pacific shows the fastest growth, propelled by rising PAD prevalence and expanding insurance coverage.

6. Who are the top companies competing in this space?

Top companies include Medtronic, Abbott Laboratories, Boston Scientific, Gore Medical, and Terumo. These firms dominate through extensive product portfolios, strong R&D pipelines, strategic acquisitions, and global distribution networks that reinforce their market leadership in peripheral artery disease devices.

7. What future opportunities are emerging for innovators?

Future opportunities arise from personalized medicine, integration of drug‑eluting technologies, AI‑guided procedural planning, and expansion into underserved markets. Companies that develop modular platforms compatible with emerging imaging modalities can capture new revenue streams as the future outlook evolves.

8. How are emerging technologies reshaping device development?

Advanced technologies such as bioresorbable scaffolds, nanocoatings, and robotics are reshaping device performance, reducing restenosis rates, and enabling precise navigation through tortuous vessels. These innovations enhance clinical outcomes and are pivotal in defining the market’s technological trajectory.

9. What is the regulatory landscape affecting market entry?

Regulatory pathways vary globally; the FDA’s 510(k) and PMA routes dominate U.S. approvals, while the EU’s MDR demands rigorous clinical evidence. Harmonization efforts and early engagement with authorities are essential to mitigate delays and ensure market entry compliance.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Peripheral Artery Disease Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.20 billion
Revenue forecast in 2033	5.66 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Boston Scientific; Cook Medical; Cardinal Health; C. R. Bard; Medtronic; Terumo; The Spectranetics; AngioDynamics; BIOTRONIK; B. Braun Melsungen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options